Showing results (551-560 of 9,976) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|April 10, 2010
Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor modelsWilliam M Siders, Jacqueline Shields, Carrie Garron, et al.Leukemia & Lymphoma|March 31, 2010
Gastrointestinal complications in children with acute myeloid leukemiaTyler L V Gray, Chee Y Ooi, Dat Tran, et al.Leukemia & Lymphoma|March 31, 2010
Neutrophil function after bone marrow and hematopoietic stem cell transplantCharulata Ramaprasad, Stephanie Pouch, David L PitrakLeukemia & Lymphoma|May 7, 2010
Autologous transplant of follicular lymphoma in the era of rituximabMathias Witzens-Harig, Peter DregerLeukemia & Lymphoma|April 17, 2010
Proliferative Hairy Cell Leukaemia (HCL-v) Resistant to Alpha-Interferon: Clinical, Diagnostic and In-Vitro Cellular CharacteristicsC S Scott, K M Hunt, R A Jones, et al.Leukemia & Lymphoma|April 17, 2010
The Splenic White Pulp in Chronic Lymphocytic Leukaemia: A Microenvironment Associated with CR2 (CD21) Expression, Cell Transformation and ProliferationI A Lampert, U Hegde, S Van NoordenLeukemia & Lymphoma|April 17, 2010
Differences in Prognostic Factors between Diffuse Non-Hodgkin's Lymphoma and Lymphoma Type of Adult T-Cell LeukemiaM Matsuzaki, Y Shimamoto, K Ono, et al.Leukemia & Lymphoma|April 17, 2010
Allogeneic Bone Marrow Transplantation for Familial Erythrophagocytic Lymphohistiocytosis, with High Dose VP16-Containing Conditioning RegimenS Todo, F Fujiwara, S Ikushima, et al.Leukemia & Lymphoma|May 30, 2009
Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinibBarbara Pieńkowska-Grela, Jolanta Rygier, Renata Woroniecka, et al.Leukemia & Lymphoma|May 30, 2009
Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapyHyun-Gyung Goh, Yoo-Jin Kim, Dong-Wook Kim, et al.Pageof 998